#rocatinlimab — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #rocatinlimab, aggregated by home.social.
-
Sanofi Pulls the Plug on Amlitelimab in AD
Sanofi is halting the clinical development of amlitelimab, an OX40-ligand monoclonal antibody, in moderate-to-severe atopic dermatitis (AD). This decision…
#France #FR #Europe #EU #Sanofi #amlitelimab #atopicdermatitis #Rocatinlimab
https://www.europesays.com/france/56506/